Made in Switzerland

Weibel CDS AG is a privately owned Swiss Medical Technology Company, founded in 2010 and is headquartered at the foot of mount Säntis in Waldstatt and a Technology Center in Schaffhausen. The company has specialised in customer funded detailed research and development of affordable, innovative, user friendly, patch Injection Systems and Devices assuring safer, easier and faster delivery of Parenteral Drugs for the home, point-of-care and clinical user.

History

  • 2010

    Founded in September 2010 by the late Ludwig Weibel, the company engages in the development of injection devices, drug delivery systems and novel packaging solutions.

  • 2011

    Weibel CDS first passed the ISO 9001 and ISO 13485 certifications and was successfully re-certified in 2014 and 2017. Development of the flexible form factor MiniBag primary packaging solution started.

  • 2012

    Pharmapack, the first product solution, the SuperCapSyringe was presented. Early 2012 Weibel CDS AG, was the first company to receive the STARTFELD Diamant Award issued to the most innovative start-up company. September 2012 Weibel CDS AG was awarded the CTI Start-up Label and received the certification «ready for sustainable business development» issued by the CTI, now Innosuisse, the Swiss Innovation Promotion Agency, a federal entity under public law.

  • 2013

    Successfully concluded first filling of insulin into the MiniBag as basis of a successful stability study leading to various studies with biologic drugs.

  • 2014

    The Reconstyringe was introduced and was first in offering fully automated reconstitution of drugs. Like a Swiss watch, it runs through the full reconstitution cycle.

  • 2015

    Extension of drug delivery device solutions, including high volume and high viscosity MiniBag based systems.

  • 2016

    Pharmapack – exhibited the new cartridge based DrugDeliverySystem and proofing its power by emptying the largest ever used cartridge. Launch of the Squeezer test system enabling fast and easy stability and preclinical testing of drugs.

  • 2017

    Development of the LyCaJect – bringing automatic reconstitution of lyophilized drug to the point of culmination. User study of the SuperCapSyringe confirming the claim – safer, easier and faster drug delivery.

  • 2018

    Opening of the Technology Center in Schaffhausen, Switzerland. Customization of the VFDP pump used in Weibel CDS’s DrugDeliverySystems to higher volume and high viscosity requirements.

  • 2019

    Mechanical Characterisation Testing of the MiniBagSystem completed. New Design of Large Volume Wearable Injector

  • 2020

    Weibel CDS acquired by SHL Medical, a world-leading solutions provider of advance self-injection devices.

Team

Weibel CDS has highly skilled and motivated employees with a proven track record in efficient execution of complex medical device projects together with our leading industry partners

Management Team